BPMC
Assenagon Asset Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-76,270
| Closed | -$6.75M | – | 1140 |
|
|
2025
Q1 | $6.75M | Sell |
76,270
-21,083
| -22% | -$1.87M | 0.01% | 468 |
|
|
2024
Q4 | $8.49M | Sell |
97,353
-3,280
| -3% | -$286K | 0.01% | 529 |
|
|
2024
Q3 | $9.31M | Sell |
100,633
-64,612
| -39% | -$5.98M | 0.02% | 530 |
|
|
2024
Q2 | $17.8M | Sell |
165,245
-9,864
| -6% | -$1.06M | 0.04% | 290 |
|
|
2024
Q1 | $16.6M | Sell |
175,109
-94,549
| -35% | -$8.97M | 0.04% | 297 |
|
|
2023
Q4 | $24.9M | Buy |
269,658
+260,321
| +2,788% | +$24M | 0.07% | 223 |
|
|
2023
Q3 | $469K | Buy |
+9,337
| New | +$469K | ﹤0.01% | 1164 |
|
|
2023
Q2 | – | Sell |
-49,847
| Closed | -$2.24M | – | 1300 |
|
|
2023
Q1 | $2.24M | Buy |
49,847
+13,636
| +38% | +$613K | 0.01% | 775 |
|
|
2022
Q4 | $1.59M | Sell |
36,211
-23,219
| -39% | -$1.02M | 0.01% | 859 |
|
|
2022
Q3 | $3.92M | Sell |
59,430
-399,376
| -87% | -$26.3M | 0.02% | 518 |
|
|
2022
Q2 | $23.2M | Buy |
458,806
+184,099
| +67% | +$9.3M | 0.09% | 185 |
|
|
2022
Q1 | $17.5M | Buy |
274,707
+216,374
| +371% | +$13.8M | 0.05% | 235 |
|
|
2021
Q4 | $6.25M | Sell |
58,333
-187,818
| -76% | -$20.1M | 0.02% | 421 |
|
|
2021
Q3 | $25.3M | Sell |
246,151
-16,108
| -6% | -$1.66M | 0.08% | 153 |
|
|
2021
Q2 | $23.1M | Buy |
+262,259
| New | +$23.1M | 0.08% | 180 |
|
|
2020
Q4 | – | Sell |
-86,281
| Closed | -$8M | – | 988 |
|
|
2020
Q3 | $8M | Buy |
+86,281
| New | +$8M | 0.04% | 205 |
|
|
2020
Q2 | – | Sell |
-9,599
| Closed | -$561K | – | 1086 |
|
|
2020
Q1 | $561K | Buy |
9,599
+6,611
| +221% | +$386K | ﹤0.01% | 586 |
|
|
2019
Q4 | $239K | Buy |
+2,988
| New | +$239K | ﹤0.01% | 679 |
|
|
2019
Q2 | – | Sell |
-17,846
| Closed | -$1.43M | – | 971 |
|
|
2019
Q1 | $1.43M | Buy |
+17,846
| New | +$1.43M | 0.01% | 562 |
|